Tyk2-IN-23
Tyk2-IN-23 is a potent, orally active, selective TYK2 inhibitor (IC50 = 18 nM), exhibiting more than > 70-fold selectivity over JAK1/2/3 isoforms. Tyk2-IN-23 potently inhibits p-STAT3 in TYK2-dependent signaling activated by IFN-α and IL-10. Tyk2-IN-23 potently inhibits IFN-α-induced STAT1 phosphorylation in H9 cells. Tyk2-IN-23 can be used for the study of alopecia areata and allergic Rhinitis.
For research use only. We do not sell to patients.
- CAS No.: 2734918-75-1
- Formula: C26H27ClFN5O2
- Molecular Weight:495.98
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Tyk2-IN-23 (Compound 29i) (50 nM-10 μM, 80 min) potently inhibits p-STAT3 in TYK2-dependent signaling activated by IFN-α (IC50 = 230.6 nM) and IL-10 (IC50 = 501.6 nM), but p-STAT3 induction by IL-21, IL-23, or IL-27 results in only marginal inhibition (IC50 > 2700 nM) in human peripheral blood mononuclear cells (hPBMC)[1].
Tyk2-IN-23 (0-10 μM, 1.5 h) potently inhibits IFN-α-induced STAT1 phosphorylation in H9 cells; in contrast, GM-CSF-induced STAT5 phosphorylation (JAK2-dependent), IL-4-induced STAT6 phosphorylation (JAK1/JAK3-mediated), and IL-6-induced STAT3 phosphorylation (JAK1/JAK2/TYK2-cooperative) remain unaffected even at 10000 nM[1].
Tyk2-IN-23 (0.625-40 μM, 24 h) shows no cytotoxicity at concentrations ≤ 10 μM in RBL-2H3 cells[1].
Tyk2-IN-23 (0-5 μM, 30 min) concentration-dependently inhibits the release of β-hexosaminidase from
Compound 48/80 trihydrochloride (HY-130592) (C48/80)-induced RBL-2H3 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RBL-2H3 cells
-
Concentration:0.625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM
-
Incubation Time:24 h
-
Result:Showed no cytotoxicity at concentrations ≤ 10 μM in RBL-2H3 cells.
-
Cell Line:H9 cells, THP-1 cells, TF-1 cells
-
Concentration:10 nM, 50 nM, 100 nM, 500 nM, 1000 nM, 5000 nM, 10000 nM
-
Incubation Time:Preincubated for 1h, then stimulated by IFN-α (1,000 U/mL) for 30 min
-
Result:Significantly inhibited IFN-α-induced STAT1 phosphorylation in H9 cells.
No significant inhibitory effect on IL-4-induced STAT6 phosphorylation in THP-1 cells.
No significant inhibitory effect on GM-CSF-induced STAT5 and IL-6-induced STAT3 phosphorylation in TF-1 cells.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female C57BL/6J mice (6-8 weeks old) underwent basal sensitization via intraperitoneal injections (every other day for 14 days) of 50 μg OVA and 2 mg aluminum hydroxide dissolved in 200 μL saline (0.9 %), from days 14-20, daily nasal challenges were performed with 2 % OVA solution (10 μL per nostril)[1].
-
Dosage:20 mg/kg, 40 mg/kg
-
Administration:Intranasal drops, once daily for 8 days
-
Result:Dose-dependently reduced AR symptoms (frequency of sneezing and nose scratching).
Reduced OVA-specific IgE (OVA-sIgE) levels.
Alleviated inflammatory cell infiltration and epithelial proliferation in the nasal mucosa.
Reduced mast cell infiltration and degranulation rate.
Reduced eosinophil infiltration.
Inhibited goblet cell proliferation.
-
Animal Model:Using female C57BL/6J mice (6-8 weeks old), Alopecia areata (AA) was induced by hair removal and cyclophosphamide injection[1].
-
Dosage:15 mg/kg, 30 mg/kg
-
Administration:Oral gavage, once daily for 26 days
-
Result:Promoted hair regeneration in a dose-dependent manner, with a significant increase in hair length and density in the high-dose group (30 mg/kg).
Decreased in pro-inflammatory factors (TNF-α and IL-23) and an increase in the anti-inflammatory factor IL-10.
Chemical Information
-
CAS No. 2734918-75-1
-
Molecular Weight 495.98
-
Formula C26H27ClFN5O2
-
SMILES
O=C1NCCC21CCN(C3=C(C)C=NC(NC4=CC=C(OCC5=CC=CC(F)=C5)C(Cl)=C4)=N3)CC2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)